Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
A phase 2 randomised controlled trial published in the New England Journal of Medicine (2023) reported substantial weight loss and improvements in glycaemic parameters, though the trial was conducted in a closely monitored clinical setting with defined eligibility criteria
Agmon, E., Solon, J., Bassereau, P
10.1038/35069004 98 KaraM.AydinT.AranT.TurktekinN.OzdemirB
This may be due to reduced calorie intake or your body adjusting to new blood sugar levels
Short-term storage: 2-8C acceptable
Funding This work was supported by the Natural Science Foundation of Heilongjiang Province (LH2023C028)
US$ 22.49
US$ 22.49
US$ 21.50
US$ 23.71
US$ 23.20
US$ 25.49
US$ 20.63
US$ 27.58
US$ 23.59
